Design of respirable sprayed microparticles of encapsulated bacteriophages

Antibiotic resistance is exponentially increasing, and the number of deaths caused by bacterial infections is expected to surge. When dealing with the respiratory system, inefficient antibiotics heighten the chance of death from bacterial infection. However, the alternatives to antibiotics are limit...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto Baldelli (Author), Mingtao Liang (Author)
Format: Book
Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8e8a69e653804d8888afdea4aec50b12
042 |a dc 
100 1 0 |a Alberto Baldelli  |e author 
700 1 0 |a Mingtao Liang  |e author 
245 0 0 |a Design of respirable sprayed microparticles of encapsulated bacteriophages 
260 |b Frontiers Media S.A.,   |c 2023-06-01T00:00:00Z. 
500 |a 2674-0850 
500 |a 10.3389/fddev.2023.1209534 
520 |a Antibiotic resistance is exponentially increasing, and the number of deaths caused by bacterial infections is expected to surge. When dealing with the respiratory system, inefficient antibiotics heighten the chance of death from bacterial infection. However, the alternatives to antibiotics are limited. Bacteriophages are a valid option since they can target a specific type of bacterium. Bacteriophages are highly specific and can avoid any side effects when delivered. However, their poor stability makes their use inefficient. Encapsulation is commonly used to protect any bioactive compound for different types of delivery. In the case of respiratory delivery, particle engineering is used to generate stable dry powders to target the nasal or lung areas. This review article provides a guideline for engineering a process of nasal dry powders of encapsulated bacteriophages. 
546 |a EN 
690 |a particle engineering 
690 |a respiratory delivery 
690 |a spraying techniques 
690 |a phage therapy 
690 |a bacteriophage 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Drug Delivery, Vol 3 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fddev.2023.1209534/full 
787 0 |n https://doaj.org/toc/2674-0850 
856 4 1 |u https://doaj.org/article/8e8a69e653804d8888afdea4aec50b12  |z Connect to this object online.